FDA grants Beyond Air's LungFit GO breakthrough device status for lung disease
Go back to FDA grants Beyond Air's LungFit GO breakthrough device status for lung disease| (NASDAQ: XAIR) | Delayed: 3.38 -0.15 (4.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.53 | 52 Week High | $ | |||
| Open | $3.51 | 52 Week Low | $ | |||
| Day High | $3.58 | P/E | N/A | |||
| Day Low | $3.32 | EPS | $ | |||
| Volume | 83,951 | |||||
